Chapter 1. Global Pet Medication Market – Scope & Methodology
1.1 Market Segmentation
1.2 Scope, Assumptions & Limitations
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Global Pet Medication Market – Executive Summary
2.1 Market Size & Forecast – (2022 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.2.1 Demand Side
2.2.2 Supply Side
2.3 Attractive Investment Propositions
2.4 COVID-19 Impact Analysis
Chapter 3. Global Pet Medication Market – Competition Scenario
3.1 Market Share Analysis & Company Benchmarking
3.2 Competitive Strategy & Development Scenario
3.3 Competitive Pricing Analysis
3.4 Supplier-Distributor Analysis
Chapter 4. Global Pet Medication Market Entry Scenario
4.1 Regulatory Scenario
4.2 Case Studies – Key Start-ups
4.3 Customer Analysis
4.4 PESTLE Analysis
4.5 Porters Five Force Model
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Powers of Customers
4.5.3 Threat of New Entrants
4.5.4 Rivalry among Existing Players
4.5.5 Threat of Substitutes
Chapter 5. Global Pet Medication Market – Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Global Pet Medication Market – By Type
6.1 Introduction/Key Findings
6.2 OTC
6.3 Rx
6.4 Y-O-Y Growth trend Analysis By Type
6.5 Absolute $ Opportunity Analysis By Type, 2023-2030
Chapter 7. Global Pet Medication Market – By Animal Type
7.1 Introduction/Key Findings
7.2 Production
7.3 Poultry
7.4 Swine
7.5 Cattle
7.6 Sheep & Goats
7.7 Fish
7.8 Companion
7.9 Dogs
7.10 Cats
7.11 Horses
7.12 Others
7.13 Y-O-Y Growth trend Analysis By Animal Type
7.14 Absolute $ Opportunity Analysis By Animal Type, 2023-2030
Chapter 8. Global Pet Medication Market – By Product Type
8.1 Introduction/Key Findings
8.2 Biologics
8.3 Vaccine
8.4 Live Attenuated Vaccines
8.5 DNA Vaccines
8.6 Recombinant Vaccines
8.7 Inactivated Vaccines
8.8 Others
8.9 Others
8.10 Pharmaceuticals
8.11 Parasiticides
8.12 Anti-infectives
8.13 Anti-inflammatory
8.14 Analgesics
8.15 Others
8.16 Medicated Feed Additives
8.17 Y-O-Y Growth trend Analysis By Product Type
8.18 Absolute $ Opportunity Analysis By Product Type, 2023-2030
Chapter 9. Global Pet Medication Market – By Administration Method
9.1 Introduction/Key Findings
9.2 Oral
9.3 Powder
9.4 Tablets
9.5 Parenteral
9.6 Others
9.7 Suspension
9.8 Topical
9.9 Carrier
9.10 Y-O-Y Growth trend Analysis By Administration Method
9.11 Absolute $ Opportunity Analysis By Administration Method, 2023-2030
Chapter 10. Global Pet Medication Market – By Distribution Channel
10.1 Introduction/Key Findings
10.2 Online
10.3 Offline
10.4 Pharmacy/Drug Store
10.5 Veterinary Hospitals/Clinics
10.6 Others
10.7 Y-O-Y Growth trend Analysis By Distribution Channel
10.8 Absolute $ Opportunity Analysis By Distribution Channel, 2023-2030
Chapter 11. Global Pet Medication Market , By Geography – Market Size, Forecast, Trends & Insights
11.1 North America
11.1.1 By Country
11.1.1.1 U.S.A.
11.1.1.2 Canada
11.1.1.3 Mexico
11.1.2 By Type
11.1.3 By Animal Type
11.1.4 By Product Type
11.1.5 By Administration Method
11.1.6 By Industry Vertical
11.1.7 Countries & Segments - Market Attractiveness Analysis
11.2 Europe
11.2.1 By Country
11.2.1.1 U.K
11.2.1.2 Germany
11.2.1.3 France
11.2.1.4 Italy
11.2.1.5 Spain
11.2.1.6 Rest of Europe
11.2.2 By Type
11.2.3 By Animal Type
11.2.4 By Product Type
11.2.5 By Administration Method
11.2.6 By Distribution Channel
11.2.7 Countries & Segments - Market Attractiveness Analysis
11.3 Asia Pacific
11.3.1 By Country
11.3.1.1 China
11.3.1.2 Japan
11.3.1.3 South Korea
11.3.1.4 India
11.3.1.5 Australia & New Zealand
11.3.1.6 Rest of Asia-Pacific
11.3.2 By Type
11.3.3 By Animal Type
11.3.4 By Product Type
11.3.5 By Administration Method
11.3.6 By Distribution Channel
11.3.7 Countries & Segments - Market Attractiveness Analysis
11.4 South America
11.4.1 By Country
11.4.1.1 Brazil
11.4.1.2 Argentina
11.4.1.3 Colombia
11.4.1.4 Chile
11.4.1.5 Rest of South America
11.4.2 By Type
11.4.3 By Animal Type
11.4.4 By Product Type
11.4.5 By Administration Method
11.4.6 By Distribution Channel
11.4.7 Countries & Segments - Market Attractiveness Analysis
11.5 Middle East & Africa
11.5.1 By Country
11.5.1.1 United Arab Emirates (UAE)
11.5.1.2 Saudi Arabia
11.5.1.3 Qatar
11.5.1.4 Israel
11.5.1.5 South Africa
11.5.1.6 Nigeria
11.5.1.7 Kenya
11.5.1.8 Egypt
11.5.1.9 Rest of MEA
11.5.2 By Type
11.5.3 By Animal Type
11.5.4 By Product Type
11.5.5 By Administration Method
11.5.6 By Distribution Channel
11.5.7 Countries & Segments - Market Attractiveness Analysis
Chapter 12. Global Pet Medication Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
12.1 KRKA
12.2 Ourofino Animal Health
12.3 Boehringer Ingelheim
12.4 Merck Animal Health
12.5 Covetrus
12.6 Company 6
12.7 Company 7
12.8 Company 8
12.9 Company 9
12.10 Company 10
2850
5250
4500
1800